{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-090511","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2023-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.914175+00:00","generated_at":"2026-06-11T16:06:01.959511+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Theriva Biologics amends bylaws to adopt advance notice provisions for stockholder proposals","bullets":["Board amended and restated bylaws effective October 3, 2023.","New Section 1.11 requires advance notice for director nominations and other stockholder proposals.","Notice must be delivered at least 120 days before anniversary of prior year's annual meeting.","Stockholder notice must comply with detailed requirements in Section 1.11(c) and (e)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-090511","json":"https://secwatch.observer/filing/0001104659-23-090511.json","markdown":"https://secwatch.observer/filing/0001104659-23-090511.md","text":"https://secwatch.observer/filing/0001104659-23-090511.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465923090511/0001104659-23-090511-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465923090511/tm2323521d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T16:06:01.959511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d6a3bdfea8aa9c70905c26c2fef366e0e92003e","claim":"Theriva Biologics, Inc.: Amended and restated bylaws to add advance notice procedures for director nominations and stockholder proposals (effective 2023-10-03).","evidence_excerpt":"On August 9, 2023, the Board of Directors (the “Board”) of Theriva Biologics, Inc., a Nevada corporation (the “Company”) amended and restated the Company’s amended and restated bylaws (the “Bylaws”), effective October 3, 2023. The Bylaws include new provisions related to advance notice procedures.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/894158/000110465923090511/0001104659-23-090511-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-10-03"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}